Lansoprazole Teva Pharma

Lansoprazole, the active ingredient in Lansoprazole Teva Pharma, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazole Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Lansoprazole is a proton pump inhibitor used to manage disorders related to excess gastric acid.

Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. Erosive esophagitis: heals erosive lesions in the esophagus. Peptic ulcer disease: promotes ulcer healing and reduces recurrence. Helicobacter pylori eradication (as part of combination therapy): enhances eradication rates by suppressing acid.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate headache. - Diarrhea: loose stools. - Nausea: feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Stevens‑Johnson syndrome: severe skin reaction.

When prescribing Lansoprazole, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for Helicobacter pylori infection: confirm eradication status after therapy. - Monitor for osteoporosis: long‑term use may affect calcium absorption. - Use with caution in elderly: higher risk of fractures and infections. - Avoid concomitant use with drugs that require acidic pH for absorption: may reduce their effectiveness. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lansoprazole can alter the pharmacokinetics of several medicines, leading to clinically relevant interactions.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced absorption, may lose efficacy. - Antifungal agents (e.g., ketoconazole, itraconazole): decreased bioavailability.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Clopidogrel: reduced activation, monitor antiplatelet effect. - Digoxin: increased serum levels, monitor for toxicity. - Methotrexate: reduced renal clearance, monitor levels.